Early-Stage Non–Small-Cell Lung Cancer: Current Perspectives in Combined-Modality Therapy

PA Bunn Jr - Clinical lung cancer, 2004 - Elsevier
The most effective treatment for patients with early-stage non–small-cell lung cancer
(NSCLC) remains complete surgical resection, providing the disease is medically operable …
被引用次数：34 相关文章

Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy.

PA Bunn Jr - Clinical Lung Cancer, 2004 - europepmc.org
The most effective treatment for patients with early-stage non-small-cell lung cancer
(NSCLC) remains complete surgical resection, providing the disease is medically operable …

Early-Stage Non–Small-Cell Lung Cancer: Current Perspectives in Combined-Modality Therapy

PA Bunn - Clinical Lung Cancer, 2004 - clinical-lung-cancer.com
The most effective treatment for patients with early-stage non–small-cell lung cancer
(NSCLC) remains complete surgical resection, providing the disease is medically operable …

Early-stage non-small-cell lung cancer: current perspectives in combined-modality therapy

PA Bunn Jr - Clinical lung cancer, 2004 - pubmed.ncbi.nlm.nih.gov
The most effective treatment for patients with early-stage non-small-cell lung cancer
(NSCLC) remains complete surgical resection, providing the disease is medically operable …

Early-Stage Non–Small-Cell Lung Cancer: Current Perspectives in Combined-Modality Therapy

PA Bunn - Clinical Lung Cancer, 2004 - infona.pl
The most effective treatment for patients with early-stage non–small-cell lung cancer
(NSCLC) remains complete surgical resection, providing the disease is medically operable …